Considering other biomarkers, we could confirm previous results by other groups showing a highly significant difference between Neurofilament light chain levels in general in FTD patients in comparison to controls with other neurological diseases ( 27 ).
← all excerpts
CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
1
—
—